Labriformin
Molecular Formula:
C31H43NO8S
InChI: InChI=1/C31H43NO8S/c1-16-25(34)30(32-10-11-41-30)31(36)26(38-16)39-22-13-18-4-5-21-20(27(18,2)14-23(22)40-31)6-8-28(3)19(7-9-29(21,28)35)17-12-24(33)37-15-17/h10,12,16,18-23,25-26,34-36H,4-9,11,13-15H2,1-3H3/t16-,18-,19-,20u,21u,22-,23-,25?,26+,27+,28-,29+,30?,31?/m1/s1
InChIKey: InChIKey=OJDKVUZIXKHTDF-MNQWFSIQBT
SMILES: CC1C(C2(C3(C(O1)OC4CC5CCC6C(C5(CC4O3)C)CCC7(C6(CCC7C8=CC(=O)OC8)O)C)O)N=CCS2)O
Names:
Card-20(22)-enolide, 2,3-((6,10-dihydroxy-9-methyl-8-oxa-1-thia-4-azaspiro(4.5)dec-3-ene-6,7-diyl)bis(oxy))-14-hydroxy-, (2-alpha(7S,9R),3-beta,5-alpha)-
CARD-20(22)-ENOLIDE, 2,3-((6,10-DIHYDROXY-9-METHYL-8-OXA-1-THIA-4-AZASPIRO(4.5)D
Labriformine
Labriformin
66419-07-6
Registries:
PubChem CID 47925
PubChem ID 187128
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|